Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

OptimizeRx Corp Director's Dealing 2011

Oct 17, 2011

33090_dirs_2011-10-17_c67859e8-bcfb-41c6-8caa-a5d50899c13e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2011-08-05

Reporting Person: KRANIAK RICHARD (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-01-11 Common Stock P 150 $2.66 Acquired 1497250 Direct
2010-05-24 Common Stock A 25000 $0.35 Acquired 1522250 Direct
2011-06-07 Common Stock J 26000 $1.05 Disposed 1496250 Direct
2011-06-08 Common Stock J 24000 $1.05 Disposed 1472250 Direct
2011-06-27 Common Stock J 50000 $0.01 Disposed 1422250 Direct
2011-08-05 Common Stock J 60000 $0.90 Disposed 1362250 Direct

Footnotes

F1: Includes 28,800 shares of the Issuer held in the name of his sons.

F2: Mr. Kraniak was issued shares of the Issuer in exchange for warrants exercised at $0.35 per share.

F3: Includes 28,800 shares of the Issuer held in the name of his sons and 48,100 shares of the Issuer held in the name of his wife.

F4: Mr. Kraniak sold 26,000 shares of the Issuer in a private transaction at $1.05 per share.

F5: Mr. Kraniak sold 24,000 shares of the Issuer in a private transaction at $1.05 per share.

F6: Mr. Kraniak sold 50,000 shares of the Issuer in a private transaction at $0.01 per share.

F7: Mr. Kraniak sold 60,000 shares of the Issuer in a private transaction at $0.90 per share.